Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 547

    1.

    Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians.

    Vijan S, Hayward RA; American College of Physicians.

    Ann Intern Med. 2004 Apr 20;140(8):650-8. Review.PMID: 15096337 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.

    Snow V, Aronson MD, Hornbake ER, Mottur-Pilson C, Weiss KB; Clinical Efficacy Assessment Subcommittee of the American College of Physicians.

    Ann Intern Med. 2004 Apr 20;140(8):644-9.PMID: 15096336 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

    Evans M, Roberts A, Davies S, Rees A.

    Drugs. 2004;64(11):1181-96. Review.PMID: 15161326 [PubMed - indexed for MEDLINE]Related articles

    4.

    Summaries for patients. Control of lipids in patients with type 2 diabetes: recommendations from the American College of Physicians.

    [No authors listed]

    Ann Intern Med. 2004 Apr 20;140(8):I85. No abstract available. PMID: 15096362 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.

    Huang ES, Meigs JB, Singer DE.

    Am J Med. 2001 Dec 1;111(8):633-42.PMID: 11755507 [PubMed - indexed for MEDLINE]Related articles

    6.

    Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

    Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators.

    Lancet. 2004 Aug 21-27;364(9435):685-96.PMID: 15325833 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

    Costa J, Borges M, David C, Vaz Carneiro A.

    BMJ. 2006 May 13;332(7550):1115-24. Epub 2006 Apr 3. Review.PMID: 16585050 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

    Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group.

    Diabetes Care. 2003 Oct;26(10):2713-21.PMID: 14514569 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.

    Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL.

    Ann Intern Med. 2007 Sep 18;147(6):386-99. Epub 2007 Jul 16. Review. Erratum in: Ann Intern Med. 2007 Dec 18;147(12):887. PMID: 17638715 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

    Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group.

    Lancet. 2003 Jun 14;361(9374):2005-16.PMID: 12814710 [PubMed - indexed for MEDLINE]Related articles

    11.

    Management of lipid disorders in the elderly.

    Playford DA, Watts GF.

    Drugs Aging. 1997 Jun;10(6):444-62. Review.PMID: 9205850 [PubMed - indexed for MEDLINE]Related articles

    12.

    Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

    Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

    Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.PMID: 18485273 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

    Vrecer M, Turk S, Drinovec J, Mrhar A.

    Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.PMID: 14692706 [PubMed - indexed for MEDLINE]Related articles

    14.

    A systematic review and economic evaluation of statins for the prevention of coronary events.

    Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

    Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.PMID: 17408535 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

    Daskalopoulou SS, Mikhailidis DP.

    Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.PMID: 16574035 [PubMed - indexed for MEDLINE]Related articles

    16.

    A review of the efficacy of rosuvastatin in patients with type 2 diabetes.

    Tuomilehto J, Leiter LA, Kallend D.

    Int J Clin Pract Suppl. 2004 Oct;(143):30-40. Review.PMID: 16035394 [PubMed - indexed for MEDLINE]Related articles

    17.

    Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.

    Udawat H, Goyal RK.

    Indian Heart J. 2001 Mar-Apr;53(2):172-6.PMID: 11428472 [PubMed - indexed for MEDLINE]Related articles

    18.

    WITHDRAWN: Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus.

    Fuller J, Stevens LK, Chaturvedi N, Holloway JF.

    Cochrane Database Syst Rev. 2007 Jul 18;(4):CD002188. Review.PMID: 17636699 [PubMed - indexed for MEDLINE]Related articles

    19.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

    J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.PMID: 15358046 [PubMed - indexed for MEDLINE]Related articles

    20.

    Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

    Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.PMID: 15297292 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data